24
Views
0
CrossRef citations to date
0
Altmetric
Haematology/Immunology

Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey

&
Pages 666-675 | Received 18 Nov 2008, Accepted 20 Jan 2009, Published online: 10 Dec 2009

References

  • Miyakis S, Lockshin MD, Atsumi T, et al International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006. 4: 295–306.
  • Hughes G. Hughes syndrome. The antiphospholipid syndrome—a clinical overview. Clin Rev Allergy Immunol 2007. 32: 3–11.
  • Wong R, Favaloro EJ. Clinical features, diagnosis and management of the antiphospholipid syndrome. Semin Thromb Hemost 2008. 34: 295–304.
  • Favaloro EJ, Wong RCW. Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: A potpourri of problems, a compilation of possible solutions. Semin Thromb Hemost 2008. 34: 389–410.
  • Andreoli L, Rizzini S, Allegri F, Meroni P, Tincani A. Are the current attempts at standardisation of antiphospholipid antibodies still useful? Emerging technologies signal a shift in direction. Semin Thromb Hemost 2008. 34: 356–60.
  • Galli M. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome. Semin Thromb Hemost 2008. 34: 329–34.
  • Galli M, Luciani D, Bertolini G, Barbui T. Anti-b2-glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003. 102: 2717–23.
  • Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors of thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003. 101: 1827–32.
  • Galli M, Barbui T. Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests. Semin Thromb Hemost 2005. 31: 17–24.
  • Pierangeli SS, Harris EN. A quarter of a century in anticardiolipin antibody testing and attempted standardization has led us to here, which is? Semin Thromb Hemost 2008. 34: 313–28.
  • Oku K, Atsumi T, Amengual O, Koike T. Antiprothrombin antibody testing: detection and clinical utility. Semin Thromb Hemost 2008. 34: 335–9.
  • Wong CWR, Favaloro EJ. A consensus approach to the formulation of guidelines for laboratory testing and reporting of antiphospholipid antibody assays. Semin Thromb Hemost 2008. 34: 361–72.
  • Wilson WA, Gharavi AE, Koike T, et al International consensus statement on preliminary classification for definite antiphospholipid syndrome. Arthritis Rheum 1999. 42: 1309–11.
  • Galli M, Reber G, De Moerloose P, deGroot PG. Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost 2008. 6: 399–401.
  • de Groot PG, Derksen RHWM, de Laat B. Twenty-two years of failure to set-up undisputed assays to detect patients with the antiphospholipid antibodies. Semin Thromb Hemost 2008. 34: 347–55.
  • Wong RCW, Gillis D, Adelstein S, et al Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology 2004. 36: 63–68.
  • Wong RC, Favaloro EJ, Adelstein S, et al Consensus guidelines on anti-beta2 glycoprotein I testing and reporting. Pathology 2008. 40: 58–63.
  • Wong R, Favaloro EJ. Antiphospholipid antibodies and the antiphospholipid syndrome I: Pathogenesis, clinical features, diagnosis and management. Preface. Semin Thromb Hemost 2008. 34: 213–8.
  • Favaloro EJ, Wong R. Antiphospholipid antibodies and the antiphospholipid syndrome II: Limitations, standardisation and clinical utility of laboratory testing. Preface. Semin Thromb Hemost 2008. 34: 309–12.
  • Asherson RA. The primary, secondary, catastrophic and seronegative variants of the antiphospholipid syndrome: A personal history long in the making. Semin Thromb Hemost 2008. 34: 227–35.
  • Asherson RA, Cervera R, Merrill JT, Erkan D. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Semin Thromb Hemost 2008. 34: 256–66.
  • Tripodi A. Laboratory testing for lupus anticoagulants: diagnostic criteria and use of screening, mixing and confirmatory studies. Semin Thromb Hemost 2008. 34: 373–9.
  • Ledford-Kraemer MR. Laboratory testing for lupus anticoagulants: Pre-examination variables, mixing studies and diagnostic criteria. Semin Thromb Hemost 2008. 34: 380–8.
  • Favaloro EJ, Bonar R, Sioufi J, et al (on behalf of the RCPA QAP in Haematology). Multi-laboratory testing of thrombophilia: Current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program in Haematology. Semin Thromb Hemost 2005. 31: 49–58.
  • Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, de Groot PG. Official communication of the scientific and standardization committee on lupus anticoagulant/phospholipid-dependent antibodies: update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009; 7: 1737–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.